Literature DB >> 7590349

A mRNA variant encoding a soluble form of 4-1BB, a member of the murine NGF/TNF receptor family.

M Setareh1, H Schwarz, M Lotz.   

Abstract

The murine 4-1BB gene, encoding a member of the nerve growth factor/tumor necrosis factor (NGF/TNF) receptor family, is thought to be selectively expressed in T cells and is involved in the regulation of lymphocyte proliferation. We detected two forms of the 4-1BB mRNA by RT-PCR which were expressed in an activation-dependent pattern in splenocytes and thymocytes. cDNA sequencing showed that the smaller form was a mRNA splice variant lacking the transmembrane region (4-1BB delta TM), because of the deletion of exon 8. The two forms of mRNA are differentially expressed in murine T cells, macrophages, 3T3 fibroblasts and epitheloid cells. Northern blotting also identifies two forms of mRNA of 1.5 and 2.4 kb, and the cell-type-specific pattern correlated with the PCR results. These results identify a novel form of 4-1BB. This and the previously known membrane-associated form have a broad tissue distribution, suggesting a more diverse role in host defense.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590349     DOI: 10.1016/0378-1119(95)00349-b

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  Regulation of mouse 4-1BB expression: multiple promoter usages and a splice variant.

Authors:  Jung D Kim; Chang H Kim; Byoung S Kwon
Journal:  Mol Cells       Date:  2011-01-11       Impact factor: 5.034

2.  CD137 signaling in Hodgkin and Reed-Sternberg cell lines induces IL-13 secretion, immune deviation and enhanced growth.

Authors:  Sakthi Rajendran; Weng Tong Ho; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2016-04-29       Impact factor: 8.110

3.  NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.

Authors:  Andrea Gras Navarro; Justyna Kmiecik; Lina Leiss; Mateusz Zelkowski; Agnete Engelsen; Øystein Bruserud; Jacques Zimmer; Per Øyvind Enger; Martha Chekenya
Journal:  J Immunol       Date:  2014-11-07       Impact factor: 5.422

4.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

5.  The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

Authors:  Kritika Kachapati; David E Adams; Yuehong Wu; Charles A Steward; Daniel B Rainbow; Linda S Wicker; Robert S Mittler; William M Ridgway
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

6.  Species difference of CD137 ligand signaling in human and murine monocytes.

Authors:  Qianqiao Tang; Dongsheng Jiang; Zhe Shao; Julia M Martínez Gómez; Herbert Schwarz
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

7.  Differential use of signal peptides and membrane domains is a common occurrence in the protein output of transcriptional units.

Authors:  Melissa J Davis; Kelly A Hanson; Francis Clark; J Lynn Fink; Fasheng Zhang; Takeya Kasukawa; Chikatoshi Kai; Jun Kawai; Piero Carninci; Yoshihide Hayashizaki; Rohan D Teasdale
Journal:  PLoS Genet       Date:  2006-04-28       Impact factor: 5.917

8.  Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging.

Authors:  Anna C Belkina; Alina Starchenko; Katherine A Drake; Elizabeth A Proctor; Riley M F Pihl; Alex Olson; Douglas A Lauffenburger; Nina Lin; Jennifer E Snyder-Cappione
Journal:  Front Immunol       Date:  2018-12-05       Impact factor: 8.786

9.  CD137 is induced by the CD40 signal on chronic lymphocytic leukemia B cells and transduces the survival signal via NF-κB activation.

Authors:  Yukana Nakaima; Ken Watanabe; Takatoshi Koyama; Osamu Miura; Tetsuya Fukuda
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

10.  CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging.

Authors:  Qianqiao Tang; Liang Kai Koh; Dongsheng Jiang; Herbert Schwarz
Journal:  Aging (Albany NY)       Date:  2013-09       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.